The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia

(2016) Norman J. Carr et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives

(2016) J. Spiliotis et al.   Current Oncology

A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

(2016) L. Villeneuve et al.   EJSO

Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database

(2016) V. Kepenekian et al.   EUROPEAN JOURNAL OF CANCER

Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array

(2016) Pierre Chirac et al.   HUMAN PATHOLOGY

Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei

(2015) Joseph Misdraji   MODERN PATHOLOGY

Réseau RENAPE : vers une nouvelle organisation des soins pour le traitement des tumeurs rares du péritoine. Description du réseau et rôle des pathologistes

(2014) Laurent Villeneuve et al.   ANNALES DE PATHOLOGIE

Current concepts in pseudomyxoma peritonei

(2014) Norman John Carr   ANNALES DE PATHOLOGIE

Mise au point sur le pseudomyxome péritonéal. Aspects anatomo-pathologiques, et implications thérapeutiques

(2014) Peggy Dartigues et al.   ANNALES DE PATHOLOGIE

Mésothéliome malin péritonéal : mise au point et données actuelles

(2014) Éliane Mery et al.   ANNALES DE PATHOLOGIE

Abdominal Desmoplastic Small Round Cell Tumor: Multimodal Treatment Combining Chemotherapy, Surgery, and Radiotherapy is the Best Option

(2014) Charles Honoré et al.   ANNALS OF SURGICAL ONCOLOGY

Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients

(2014) P. Taflampas et al.   EJSO

Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study

(2013) J. Hommell-Fontaine et al.   ANNALS OF SURGICAL ONCOLOGY

Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients

(2013) N. Bakrin et al.   EJSO

Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2012) Terence C. Chua et al.   JOURNAL OF CLINICAL ONCOLOGY

Operative Findings, Early Complications, and Long-Term Survival in 456 Patients With Pseudomyxoma Peritonei Syndrome of Appendiceal Origin

(2011) Haney Youssef et al.   DISEASES OF THE COLON & RECTUM

A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*

(2010) Tristan D. Yan et al.   CANCER

Primary peritoneal and ovarian cancers: an epidemiological comparative analysis

(2010) Delores J. Grant et al.   CANCER CAUSES & CONTROL

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

(2010) D. Baratti et al.   EJSO

Pseudomyxoma peritonei

(2010) Katharine E Bevan   World Journal of Gastrointestinal Oncology

Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution

(2009) Terence C. Chua et al.   ANNALS OF SURGICAL ONCOLOGY

Registries for Robust Evidence

(2009) Nancy A. Dreyer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mésothéliome péritonéal : traitement par l’association chirurgie de cytoréduction et chimiothérapie hyperthermique intrapéritonéale

(2009) G. Passot et al.   JOURNAL DE CHIRURGIE

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY

Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

(2008) D. Elias et al.   BRITISH JOURNAL OF SURGERY

Appendiceal neoplasms and pseudomyxoma peritonei: A population based study

(2007) R.M. Smeenk et al.   EJSO